Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics

by Laura Molenaar‐Kuijsten, Bart Albertus Wilhelmus Jacobs, Sophie Alberdine Kurk, Anne Maria May, Thomas Petrus Catharina Dorlo, Jacob Hendrik Beijnen, Neeltje Steeghs, Alwin Dagmar Redmar Huitema
Published 2021-07-01